In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow ...

HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...

Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...

These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.

It could prove to be a case of better later than never for the healthcare giant.

Could this be the secret to Pfizer's rebound strategy?

Zoetis has seen its valuation compress dramatically, now trading at just 12x trailing earnings after a 52% 12-month share ...

Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic ...